Swedencare AB (publ), the Malmö-headquartered premium pet healthcare company listed on NASDAQ First North Growth Market, has announced the formation of its Nomination Committee for the Annual General Meeting scheduled for 23 June 2027. The committee, comprising three representatives from major shareholders, was established in line with principles agreed at the company's Annual General Meeting on 23 April 2026. The appointment is a routine but significant step in Swedencare's corporate governance calendar, giving key shareholders a formal voice in shaping board composition and remuneration ahead of the 2027 meeting.
Key Points
- Swedencare AB (publ) (0ABG), listed on NASDAQ First North Growth Market and OTCQX Best Market
- Nomination Committee appointed for the AGM to be held on 23 June 2027 in Malmö, Sweden
- Committee members represent Håkan Svanberg & Co Health Care AB, Symrise AG, and JCC Group Invest Sweden AB; shareholder proposals must be submitted by 28 April 2027
- Investors should watch for the committee's formal proposals on board composition, fees, and auditor appointments when the AGM notice is published
Three Shareholders Represented on Swedencare's 2027 Nomination Committee
The Nomination Committee consists of Håkan Svanberg, appointed by Håkan Svanberg & Co Health Care AB and serving as Chairman of the committee; Diego Maurizio, appointed by Symrise AG; and Johan Bergdahl, appointed by JCC Group Invest Sweden AB. The inclusion of Symrise AG, a major strategic shareholder in Swedencare, is particularly notable given the company's focus on premium pet healthcare products sold across approximately 70 countries. The committee's formation follows the governance principles approved at the April 2026 AGM, underscoring a structured shareholder-led approach to board oversight.
Nomination Committee Remit Covers Board, Fees, and Auditor Decisions for Swedencare's AGM
According to the announcement, the Nomination Committee is tasked with submitting proposals to the 2027 AGM covering the number of board members and deputies, board composition and the identity of the Chairman, board and auditor fees, decisions on the nomination committee itself, the chairman of the AGM, and the election of auditors. These responsibilities are central to maintaining investor confidence in Swedencare, which develops, produces, and sells premium pet healthcare brands including NaturVet®, ProDen PlaqueOff®, Innovet, and nutravet®, distributed through veterinarians, pet stores, and online channels worldwide.
Shareholders Must Submit Proposals to Swedencare's Malmö Office by 28 April 2027
Any Swedencare shareholders wishing to put forward proposals for consideration must do so in writing no later than 28 April 2027, addressed to the Nomination Committee at the company's registered offices at Medeon Science Park, Per Albin Hanssons väg 41, Malmö, Sweden. The committee's final proposals will be presented in the official notice of the Annual General Meeting and published on Swedencare's corporate website. Investors monitoring the company's governance developments, particularly regarding board refreshment or changes to auditor arrangements, should note this submission deadline as a key date in the corporate calendar.





Please wait processing your request...